SK Biopharm’s constipation treatment in phase-2 trials in U.S.
IndustryMar 18, 2012
SK Biopharmaceuticals Co. said on Sunday it began phase-2 clinical trials of YKP10811, a treatment for chronic constipation, in the United States last month.The phase-2 trials are conducted on patients with chronic constipation and other gastrointestinal disorders to see if once-a-day oral dosing of the drug is effective and safe.Once the phase-2 and phase-3 trials succeed, SK Biopharm expects to begin sales of the new drug around 2016.Unlike the current treatments for constipation that rely on